← Issue №8/ week of Aug 23, 2026/Colorectal

Effectiveness of theory-based WhatsApp chatbot outreach in colorectal cancer screening uptake: a randomized controlled trial.

From GI Signals issue №8: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Colorectal rct · n=500 · Aug 19, 2026 · Clin Gastro Hep · IF 16.2

Effectiveness of theory-based WhatsApp chatbot outreach in colorectal cancer screening uptake: a randomized controlled trial.

Practice-changingcolorectal cancer screeninghealth servicesartificial intelligence
Clinical takeawayConsider implementing WhatsApp-based chatbot outreach for adults aged 50-75 in your CRC screening program. The intervention delivers health education video and tailored behavior-change messaging based on readiness stage, improving uptake by 8-9 percentage points.
What it foundWhatsApp chatbot with video education and personalized risk-assessment increased CRC screening uptake to 36% vs 27.6% at 3 months (p=0.043) in adults aged 50-75, sustained at 6 months (45.6% vs 36.4%, p=0.045)
ContextCRC screening uptake remains suboptimal despite known mortality benefit. This trial demonstrates that structured digital outreach with education and personalized risk assessment significantly outperforms minimal reminder text, refining evidence on how to close screening gaps in community populations.
Reinforcessuggested applicable standard· U.S. Multi-Society Task Force on Colorectal Cancer (Rex DK, Boland CR, Dominitz JA, et al.), "Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer," Gastroenterology, 2017

Decision at stakeHow to improve patient uptake of colorectal cancer screening among eligible individuals

Begin average-risk colorectal cancer screening at age 45 using a patient-centered shared-decision modality choice, colonoscopy every 10 years (preferred) or annual FIT as Tier 1 options, with multi-target stool DNA every 3 years, CT colonography every 5 years, or flexible sigmoidoscopy every 5 to 10 years as Tier 2 alternatives. A positive stool-based test requires diagnostic colonoscopy, and stool tests should not be ordered for patients who would decline follow-up colonoscopy. Generally stop at age 75 with individualized decisions for ages 76-85 and no screening beyond 85.

U.S. Multi-Society Task Force on Colorectal Cancer (Rex DK, Boland CR, Dominitz JA, et al.), "Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer," Gastroenterology, 2017 · reviewed 2026-07-23 ↗
Tung Lam TY … Yiu Sung JJ · Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association · IF 16.2 · PubMed ↗Permalink
← Read the whole of issue №8 Every paper GI Signals surfaces gets a page like this one. All issues